• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管活性肠肽在盆腔器官脱垂患者阴道前壁的表达。

Vasoactive intestinal peptide expression in the vaginal anterior wall of patients with pelvic organ prolapse.

机构信息

Department of Obstetrics and Gynecology, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Number 106 Zhongshan Road 2, Guangzhou 510080, China.

出版信息

Taiwan J Obstet Gynecol. 2013 Jun;52(2):233-40. doi: 10.1016/j.tjog.2013.04.014.

DOI:10.1016/j.tjog.2013.04.014
PMID:23915857
Abstract

OBJECTIVE

Perimenopausal women are at high risk for pelvic organ prolapse (POP) and stress urinary incontinence (SUI) diseases. In the present study, the expression of VIP in the vaginal epithelium of 70 perimenopausal women was correlated with the severity of POP with or without SUI.

MATERIALS AND METHODS

Seventy biopsy specimens from the anterior vaginal epithelium were obtained from postmenopausal patients. Immunohistochemical labeling for vasoactive intestinal peptide (VIP) and hematoxylin and eosin staining were performed. The VIP innervation was then compared between eight patient groups. Semiquantitative analysis of VIP protein by Western blotting was performed and compared between the eight patient groups.

RESULTS

The results of the immunohistochemical study showed that the intensity of VIP-immunoreactivity (VIP-ir) in the eight groups was as follows (in decreasing order): Control; POPI; POP II; POP II + SUI; POP III; POP IV and POP III + SUI; and POP IV + SUI. The intensity of VIP-ir was obviously weak and similar among the POP IV, POP III + SUI, and POP IV + SUI groups. This result was validated by the Western blotting analysis. The level of the VIP peptide also deceased in POP patients and was as follows (in decreasing order): Control; POPI; POP II and POP II + SUI; POP III and POP III + SUI; and POP IV and POP IV + SUI.

CONCLUSION

The present study found that reduced VIP innervation in the vaginal epithelium of the perimenopausal women was correlated with the severity of POP with or without SUI.

摘要

目的

围绝经期女性患盆腔器官脱垂(POP)和压力性尿失禁(SUI)疾病的风险很高。本研究旨在探讨围绝经期女性阴道上皮中 VIP 的表达与伴有或不伴有 SUI 的 POP 严重程度的关系。

材料与方法

从绝经后患者中获得 70 个阴道前上皮活检标本。进行血管活性肠肽(VIP)免疫组织化学标记和苏木精-伊红染色。然后比较了 8 个患者组之间的 VIP 神经支配。通过 Western blot 对 VIP 蛋白进行半定量分析,并比较 8 个患者组之间的差异。

结果

免疫组织化学研究结果显示,8 个组中 VIP 免疫反应性(VIP-ir)的强度如下(按强度降低的顺序排列):对照组;POPI 组;POP II 组;POP II + SUI 组;POP III 组;POP IV 组和 POP III + SUI 组;POP IV + SUI 组。POP IV、POP III + SUI 和 POP IV + SUI 组中 VIP-ir 强度明显较弱且相似。Western blot 分析验证了这一结果。POP 患者 VIP 肽水平也降低,按降低顺序排列为:对照组;POPI 组;POP II 组和 POP II + SUI 组;POP III 组和 POP III + SUI 组;POP IV 组和 POP IV + SUI 组。

结论

本研究发现,围绝经期女性阴道上皮中 VIP 神经支配减少与伴有或不伴有 SUI 的 POP 严重程度相关。

相似文献

1
Vasoactive intestinal peptide expression in the vaginal anterior wall of patients with pelvic organ prolapse.血管活性肠肽在盆腔器官脱垂患者阴道前壁的表达。
Taiwan J Obstet Gynecol. 2013 Jun;52(2):233-40. doi: 10.1016/j.tjog.2013.04.014.
2
Vasoactive intestinal peptide in vaginal epithelium of patients with pelvic organ prolapse and stress urinary incontinence.盆腔器官脱垂和压力性尿失禁患者阴道上皮中的血管活性肠肽
Int J Gynaecol Obstet. 2009 Jun;105(3):223-5. doi: 10.1016/j.ijgo.2009.01.033. Epub 2009 Mar 9.
3
[Etiological study of pelvic organ prolapse and stress urinary incontinence with collagen status and metabolism].[盆腔器官脱垂及压力性尿失禁与胶原状态及代谢的病因学研究]
Zhonghua Yi Xue Za Zhi. 2013 Feb 19;93(7):500-3.
4
[Expression and significance of elastin and fibulin-5 in anterior vaginal tissue of women with pelvic organ prolapse].[弹性蛋白和纤连蛋白-5在盆腔器官脱垂女性阴道前壁组织中的表达及意义]
Zhonghua Fu Chan Ke Za Zhi. 2009 Jul;44(7):514-7.
5
Neuropeptide Y innervation in the vaginal mucosa among patients with pelvic organ prolapse.神经肽 Y 支配在盆腔器官脱垂患者的阴道黏膜中的分布。
Mol Med Rep. 2012 Feb;5(2):444-8. doi: 10.3892/mmr.2011.689. Epub 2011 Nov 25.
6
Neuropeptide Y expression in vaginal epithelium of women with pelvic organ prolapse and stress urinary incontinence.盆腔器官脱垂和压力性尿失禁女性阴道上皮中神经肽Y的表达
Int J Gynaecol Obstet. 2008 Jul;102(1):65-8. doi: 10.1016/j.ijgo.2008.02.018. Epub 2008 Apr 16.
7
Role of vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide in the vaginal wall of women with stress urinary incontinence and pelvic organ prolapse.血管活性肠肽和垂体腺苷酸环化酶激活多肽在压力性尿失禁和盆腔器官脱垂女性阴道壁中的作用。
Int Urogynecol J Pelvic Floor Dysfunct. 2008 Aug;19(8):1151-7. doi: 10.1007/s00192-008-0585-z. Epub 2008 Mar 20.
8
Study on nerve fiber density in anterior vaginal epithelium for stress urinary incontinence.压力性尿失禁患者阴道前壁上皮神经纤维密度的研究
Int Urogynecol J Pelvic Floor Dysfunct. 2004 Jul-Aug;15(4):272-5. doi: 10.1007/s00192-004-1155-7.
9
[Clinical study on concomitant surgery for stress urinary incontinence and pelvic organ prolapse].压力性尿失禁与盆腔器官脱垂同期手术的临床研究
Zhonghua Wai Ke Za Zhi. 2008 Oct 15;46(20):1533-5.
10
[Study of neural expression in vaginal mucosa of patients with urinary stress incontinence].[压力性尿失禁患者阴道黏膜神经表达的研究]
Zhonghua Fu Chan Ke Za Zhi. 2004 Apr;39(4):254-6.

引用本文的文献

1
Preliminary study on mesenchymal stem cells in repairing nerve injury in pelvic floor denervation.间充质干细胞修复盆底去神经支配后神经损伤的初步研究
Front Bioeng Biotechnol. 2023 Jun 22;11:1190068. doi: 10.3389/fbioe.2023.1190068. eCollection 2023.
2
Molecular Processes in Stress Urinary Incontinence: A Systematic Review of Human and Animal Studies.压力性尿失禁中的分子过程:人类和动物研究的系统评价。
Int J Mol Sci. 2022 Mar 21;23(6):3401. doi: 10.3390/ijms23063401.
3
Advances in molecular mechanisms of pelvic organ prolapse (Review).
盆腔器官脱垂分子机制的研究进展(综述)
Exp Ther Med. 2021 Sep;22(3):1009. doi: 10.3892/etm.2021.10442. Epub 2021 Jul 15.
4
Primary Female Urethral Carcinoma: Proposed Staging Modifications Based on Assessment of Female Urethral Histology and Analysis of a Large Series of Female Urethral Carcinomas.原发性女性尿道癌:基于女性尿道组织学评估和大量女性尿道癌分析的分期修改建议。
Am J Surg Pathol. 2020 Dec;44(12):1591-1601. doi: 10.1097/PAS.0000000000001569.